National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 18995-18996 [2013-07119]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Notices
the cognizant agency or office. A current
rate covers the applicable grant
activities under the current award’s
budget period. If the current rate is not
on file with the DGM at the time of
award, the IDC portion of the budget
will be restricted. The restrictions
remain in place until the current rate is
provided to the DGM.
Generally, IDC rates for IHS grantees
are negotiated with the Division of Cost
Allocation (DCA) https://rates.psc.gov/
and the Department of Interior (Interior
Business Center) https://www.doi.gov/
ibc/services/Indirect_Cost_Services/
index.cfm. For questions regarding the
indirect cost policy, please call (301)
443–5204 to request assistance.
mstockstill on DSK4VPTVN1PROD with NOTICES
4. Reporting Requirements
The grantee must submit required
reports consistent with the applicable
deadlines. Failure to submit required
reports within the time allowed may
result in suspension or termination of
an active grant, withholding of
additional awards for the project, or
other enforcement actions such as
withholding of payments or converting
to the reimbursement method of
payment. Continued failure to submit
required reports may result in one or
both of the following: (1) The
imposition of special award provisions;
and (2) the non-funding or non-award of
other eligible projects or activities. This
requirement applies whether the
delinquency is attributable to the failure
of the grantee organization or the
individual responsible for preparation
of the reports. Reports must be
submitted electronically via
GrantSolutions. Personnel responsible
for submitting reports will be required
to obtain a login and password for
GrantSolutions. Please see the Agency
Contacts list in section VII for the
systems contact information.
The reporting requirements for this
program are noted below.
A. Progress Reports
Program progress reports are required
semiannually, within 30 days after the
budget period ends. These reports must
include a brief comparison of actual
accomplishments to the goals
established for the period, or, if
applicable, provide sound justification
for the lack of progress, and other
pertinent information as required. A
final report must be submitted within 90
days of expiration of the budget/project
period.
B. Financial Reports
Federal Financial Report FFR (SF–
425), Cash Transaction Reports are due
30 days after the close of every calendar
VerDate Mar<15>2010
20:20 Mar 27, 2013
Jkt 229001
quarter to the Division of Payment
Management, HHS at: https://
www.dpm.psc.gov. It is recommended
that the applicant also send a copy of
the FFR (SF–425) report to the Grants
Management Specialist. Failure to
submit timely reports may cause a
disruption in timely payments to the
applicant’s organization.
Grantees are responsible and
accountable for accurate information
being reported on all required reports:
the Progress Reports and FFR.
C. Federal Subaward Reporting System
(FSRS)
This award may be subject to the
Transparency Act subaward and
executive compensation reporting
requirements of 2 CFR Part 170.
The Transparency Act requires the
OMB to establish a single searchable
database, accessible to the public, with
information on financial assistance
awards made by Federal agencies. The
Transparency Act also includes a
requirement for recipients of Federal
grants to report information about firsttier subawards and executive
compensation under Federal assistance
awards.
IHS has implemented a Term of
Award into all IHS Standard Terms and
Conditions, NoAs and funding
announcements regarding the FSRS
reporting requirement. This IHS Term of
Award is applicable to all IHS grant and
cooperative agreements issued on or
after October 1, 2010, with a $25,000
subaward obligation dollar threshold
met for any specific reporting period.
Additionally, all new (discretionary)
IHS awards (where the project period is
made up of more than one budget
period) and where: 1) the project period
start date was October 1, 2010 or after
and 2) the primary awardee will have a
$25,000 subaward obligation dollar
threshold during any specific reporting
period will be required to address the
FSRS reporting. For the full IHS award
term implementing this requirement
and additional award applicability
information, visit the Grants
Management Grants Policy Web site at:
https://www.ihs.gov/
NonMedicalPrograms/gogp/
index.cfm?module=gogp_policy_topics.
Telecommunication for the hearing
impaired is available at: TTY (301) 443–
6394.
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to: Susan Karol,
MD, Chief Medical Officer, 801
Thompson Avenue, TMP Suite 400,
Rockville, MD 20852, Phone: 301–443–
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
18995
1083, Fax: 301–443–4794, Email:
Susan.Karol@ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Ms. Cherron Smith, Grants Management
Specialist, 801 Thompson Avenue, TMP
Suite 360, Rockville, MD 20852, Phone:
301–443–5204, Fax: 301–443–9602,
Email: Cherron.Smith@ihs.gtov.
3. Questions on systems matters may
be directed to: Paul Gettys, Grant
Systems Coordinator, 801 Thompson
Avenue, TMP Suite 360, Rockville, MD
20852, Phone: 301–443–2114; or the
DGM main line 301–443–5204, Fax:
301–443–9602, email:
Paul.Gettys@ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all cooperative agreement
and contract recipients to provide a
smoke-free workplace and promote the
non-use of all tobacco products. In
addition, Pub. L. 103–227, the ProChildren Act of 1994, prohibits smoking
in certain facilities (or in some cases,
any portion of the facility) in which
regular or routine education, library,
day care, health care, or early childhood
development services are provided to
children. This is consistent with the
HHS mission to protect and advance the
physical and mental health of the
American people.
Dated: March 13, 2013.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2013–07117 Filed 3–27–13; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\28MRN1.SGM
28MRN1
18996
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Notices
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Research Dissemination and Implementation.
Date: April 22, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott, 1999 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Keith A. Mintzer, Ph.D.,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7186,
Bethesda, MD 20892–7924, 301–594–7947,
mintzerk@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Ancillary Studies.
Date: April 23, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7185, Bethesda, MD 20892, 301–435–0725,
kristen.page@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07119 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Mar<15>2010
20:20 Mar 27, 2013
Jkt 229001
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Peer Review Meeting.
Date: April 4, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference
Call).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, Room 3127, Bethesda, MD
20892, 301–443–8115, gaol2@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 21, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07120 Filed 3–27–13; 8:45 am]
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health And Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07125 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Alexander Disease;
Mechanisms, Modifiers and Therapeutics.
Date: April 23, 2013.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Huntington’s Disease SEP.
Date: April 15, 2013.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–435–6033, rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 78, Number 60 (Thursday, March 28, 2013)]
[Notices]
[Pages 18995-18996]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07119]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 18996]]
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Research Dissemination and Implementation.
Date: April 22, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Crystal City Marriott, 1999 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: Keith A. Mintzer, Ph.D., Scientific Review
Officer, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD 20892-7924,
301-594-7947, mintzerk@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Ancillary Studies.
Date: April 23, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7185, Bethesda, MD 20892, 301-
435-0725, kristen.page@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-07119 Filed 3-27-13; 8:45 am]
BILLING CODE 4140-01-P
